We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




MRSA Identified Using Nasal Swabs

By LabMedica International staff writers
Posted on 13 Sep 2012
Methicillin-resistant Staphylococcus aureus (MRSA) infections have been detected by nasal swabbing using agar culture methods. More...


The proportion of patients with MRSA that were correctly identified by nasal swabs has been compared with multiple body site testing using agar and nutrient broth culture.

A cross-sectional study has been carried out by the Health Protection Scotland (Glasgow, UK) on adult patients admitted to 36 general specialty wards of two large hospitals in Scotland (UK). Patients were screened for MRSA via multiple body site swabs such as nasal, throat, axillary, perineal, wound, and invasive device sites. These were cultured individually on Brilliance MRSA chromogenic agar (Oxoid; Basingstoke, UK) and pooled in nutrient broth. Suspect colonies were confirmed by a coagulase test using the Prolex Staph Xtra Latex kit (Pro-Lab Diagnostics; Bromborough, UK). Combined results from all sites and cultures provided a gold-standard estimate of true MRSA prevalence.

The scientist found that nasal screening performed better than throat, axillary, or perineal screening, but only identified 66% of true MRSA carriers against the gold standard at an overall prevalence of 2.9%. Axillary screening performed least well. Combining nasal and perineal swabs gave the best two-site combination with 82%. When combined with realistic screening compliance rates of 80%-90%, nasal swabbing alone probably detects just over half of true colonization in practice. Swabbing of clinically relevant sites such as wounds and indwelling devices, is important for a small but high-prevalence group.

The investigators concluded that nasal swabbing is the standard method in many locations for MRSA screening. Its diagnostic efficiency in practice appears to be limited, however, and the resource implications of multiple body site screening have to be balanced against a potential clinical benefit whose magnitude and nature remains unclear. The study was published in the August 2012 issue of the journal Infection Control and Hospital Epidemiology.

Related Links:

Health Protection Scotland
Oxoid
Pro-Lab Diagnostics



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Staining Management Software
DakoLink
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.